あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/20 | 1,231 | 1,252 | 1,227 | 1,241 | +10 | +0.8% | 31,000 |
| 2023/01/19 | 1,243 | 1,250 | 1,226 | 1,231 | -12 | -1% | 46,800 |
| 2023/01/18 | 1,265 | 1,265 | 1,225 | 1,243 | -27 | -2.1% | 76,200 |
| 2023/01/17 | 1,253 | 1,275 | 1,240 | 1,270 | +17 | +1.4% | 42,300 |
| 2023/01/16 | 1,250 | 1,265 | 1,233 | 1,253 | -1 | -0.1% | 30,400 |
| 2023/01/13 | 1,274 | 1,286 | 1,253 | 1,254 | -35 | -2.7% | 57,100 |
| 2023/01/12 | 1,295 | 1,295 | 1,280 | 1,289 | +1 | +0.1% | 23,900 |
| 2023/01/11 | 1,274 | 1,299 | 1,274 | 1,288 | +22 | +1.7% | 34,000 |
| 2023/01/10 | 1,261 | 1,296 | 1,261 | 1,266 | -2 | -0.2% | 45,600 |
| 2023/01/06 | 1,236 | 1,274 | 1,236 | 1,268 | +36 | +2.9% | 38,600 |
| 2023/01/05 | 1,250 | 1,260 | 1,208 | 1,232 | -13 | -1% | 88,300 |
| 2023/01/04 | 1,291 | 1,291 | 1,244 | 1,245 | -52 | -4% | 46,600 |
| 2022/12/30 | 1,298 | 1,311 | 1,289 | 1,297 | +4 | +0.3% | 49,000 |
| 2022/12/29 | 1,264 | 1,299 | 1,264 | 1,293 | +22 | +1.7% | 50,700 |
| 2022/12/28 | 1,265 | 1,293 | 1,260 | 1,271 | -5 | -0.4% | 74,900 |
| 2022/12/27 | 1,275 | 1,282 | 1,259 | 1,276 | +1 | +0.1% | 31,300 |
| 2022/12/26 | 1,290 | 1,296 | 1,272 | 1,275 | +3 | +0.2% | 26,100 |
| 2022/12/23 | 1,270 | 1,284 | 1,263 | 1,272 | -3 | -0.2% | 50,100 |
| 2022/12/22 | 1,260 | 1,277 | 1,257 | 1,275 | +27 | +2.2% | 40,900 |
| 2022/12/21 | 1,241 | 1,260 | 1,234 | 1,248 | +8 | +0.6% | 47,200 |
| 2022/12/20 | 1,273 | 1,280 | 1,231 | 1,240 | -27 | -2.1% | 72,700 |
| 2022/12/19 | 1,263 | 1,278 | 1,260 | 1,267 | +4 | +0.3% | 49,800 |
| 2022/12/16 | 1,258 | 1,278 | 1,258 | 1,263 | +4 | +0.3% | 73,200 |
| 2022/12/15 | 1,258 | 1,270 | 1,251 | 1,259 | -8 | -0.6% | 41,500 |
| 2022/12/14 | 1,258 | 1,288 | 1,255 | 1,267 | +24 | +1.9% | 129,600 |
| 2022/12/13 | 1,239 | 1,254 | 1,233 | 1,243 | +18 | +1.5% | 43,700 |
| 2022/12/12 | 1,220 | 1,233 | 1,208 | 1,225 | +9 | +0.7% | 35,500 |
| 2022/12/09 | 1,200 | 1,233 | 1,200 | 1,216 | +8 | +0.7% | 28,200 |
| 2022/12/08 | 1,215 | 1,219 | 1,203 | 1,208 | +3 | +0.2% | 38,700 |
| 2022/12/07 | 1,212 | 1,219 | 1,203 | 1,205 | -11 | -0.9% | 44,000 |
| 2022/12/06 | 1,189 | 1,226 | 1,189 | 1,216 | +16 | +1.3% | 73,300 |
| 2022/12/05 | 1,221 | 1,221 | 1,187 | 1,200 | -26 | -2.1% | 76,500 |
| 2022/12/02 | 1,277 | 1,277 | 1,226 | 1,226 | -61 | -4.7% | 86,400 |
| 2022/12/01 | 1,276 | 1,288 | 1,271 | 1,287 | +8 | +0.6% | 56,900 |
| 2022/11/30 | 1,284 | 1,290 | 1,269 | 1,279 | +12 | +0.9% | 58,200 |
| 2022/11/29 | 1,253 | 1,275 | 1,250 | 1,267 | +8 | +0.6% | 51,100 |
| 2022/11/28 | 1,237 | 1,267 | 1,236 | 1,259 | +13 | +1% | 52,800 |
| 2022/11/25 | 1,240 | 1,252 | 1,240 | 1,246 | -1 | -0.1% | 48,200 |
| 2022/11/24 | 1,240 | 1,259 | 1,231 | 1,247 | +17 | +1.4% | 70,800 |
| 2022/11/22 | 1,205 | 1,234 | 1,203 | 1,230 | +27 | +2.2% | 85,400 |
| 2022/11/21 | 1,175 | 1,208 | 1,174 | 1,203 | +38 | +3.3% | 89,300 |
| 2022/11/18 | 1,155 | 1,168 | 1,151 | 1,165 | +16 | +1.4% | 27,800 |
| 2022/11/17 | 1,141 | 1,153 | 1,139 | 1,149 | +4 | +0.3% | 20,600 |
| 2022/11/16 | 1,137 | 1,154 | 1,133 | 1,145 | +8 | +0.7% | 22,200 |
| 2022/11/15 | 1,114 | 1,148 | 1,114 | 1,137 | +23 | +2.1% | 32,300 |
| 2022/11/14 | 1,123 | 1,124 | 1,114 | 1,114 | -7 | -0.6% | 34,900 |
| 2022/11/11 | 1,144 | 1,144 | 1,112 | 1,121 | -2 | -0.2% | 58,900 |
| 2022/11/10 | 1,145 | 1,145 | 1,121 | 1,123 | -27 | -2.3% | 59,300 |
| 2022/11/09 | 1,188 | 1,188 | 1,146 | 1,150 | -33 | -2.8% | 52,900 |
| 2022/11/08 | 1,159 | 1,187 | 1,155 | 1,183 | +36 | +3.1% | 104,200 |
551～
600
件表示中 / 991件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 237,600円 | +0.3% | +2.7% | 2.10% | 13.48倍 | 1.05倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 栄研化 | 225,300円 | +0.4% | -8.4% | 2.35% | 28.92倍 | 1.64倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 85,000円 | +22.8% | - | 0.00% | 69.44倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| クオリプス | 805,000円 | +660.9% | - | 0.00% | - | 11.68倍 |
|
大阪大学発ベンチャー。ｉＰＳ細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
| ＪＣＲファーマ | 44,700円 | -23.0% | - | 4.47% | - | 0.96倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
